Safety, Tolerability, and Pharmacokinetic and Pharmacodynamic Characteristics of JP-2266 in Healthy Subjects

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
Phase I Clinical Trial to Investigate the Safety, Tolerability, and Pharmacokinetic and Pharmacodynamic Characteristics of JP-2266 after Oral Administration in Healthy Male Caucasian Subjects
Epistemonikos ID: d4b268268a34a88c14b3aa1b2ff1e48b645cb4f1
First added on: May 09, 2024